TuHURA Biosciences, Inc.
HURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $13 | $9 | $8 | $5 |
| G&A Expenses | $0 | $4 | $2 | $2 |
| SG&A Expenses | $4 | $4 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $16 | $0 | $0 |
| Operating Expenses | $18 | $30 | $10 | $7 |
| Operating Income | -$18 | -$30 | -$10 | -$7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$4 | $0 | $1 | $0 |
| Pre-Tax Income | -$22 | -$29 | -$9 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$22 | -$29 | -$9 | -$7 |
| % Margin | – | – | – | – |
| EPS | -1.214 | -11.291 | -324.485 | -903.035 |
| % Growth | 89.3% | 96.5% | 64.1% | – |
| EPS Diluted | -1.214 | -11.291 | -324.485 | -903.035 |
| Weighted Avg Shares Out | 19 | 1 | 0 | 0 |
| Weighted Avg Shares Out Dil | 19 | 1 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$17 | -$29 | -$10 | -$6 |
| % Margin | – | – | – | – |